换一批摘要胰岛β细胞衰竭是糖尿病致病机制的核心,也是治疗2型糖尿病的关键靶点.已有众多基础及临床研究证实胰升糖素样肽1及其类似物利拉鲁肽具有葡萄糖依赖性降糖作用.同时,还具有显著改善胰岛β细胞功能的作用,为2型糖尿病的治疗提供了新的选择.
更多相关知识
abstractsThe failure of islet β cell is the core pathogenic mechanism of diabetes,which is also the key target for type 2 diabetic mellitus treatment.A large amount of basic and clinical researches have been confirmed that glucagon like peptide-1 and its analogue liraglutide have abilities to significantly improve islet β cell function besides the glucose-dependent lowering hyperglycemia effects.Furthermore,liraglutide is approved to improve β cell function,thus providing a new choice for treatment of type 2 diabetes.
More相关知识
分类号
R781.63（口腔内科学）
栏目名称
DOI
10.3760/cma.j.issn.1000-6699.2011.10.025
发布时间
2012-01-12（万方平台首次上网日期，不代表论文的发表时间）
- 浏览112
- 被引37
- 下载785
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
